5-(9,10-dihydro-5,8-dimethoxy-9,10-dioxo-anthracen-2-yl)tetrazole | 161920-51-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: 5-(9,10-dihydro-5,8-dimethoxy-9,10-dioxo-anthracen-2-yl)tetrazole
• 英文别名: 9,10-Anthracenedione, 1,4-dimethoxy-6-(1H-tetrazol-5-yl)-；1,4-dimethoxy-6-(2H-tetrazol-5-yl)anthracene-9,10-dione
• CAS: 161920-51-0
• 化学式: C₁₇H₁₂N₄O₄
• 分子量: 336.307
• InChiKey: NRUNESGKQXAVPG-UHFFFAOYSA-N

物化性质

• 沸点：
  631.6±65.0 °C(Predicted)
• 密度：
  1.459±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  107
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  9,10-Dihydro-5,8-dimethoxy-N-(1,1-dimethylethyl)-9,10-dioxoanthracene-2-carboxamide 在 sodium azide 、 五氯化磷 、 三乙胺盐酸盐 作用下， 以 水 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 5-(9,10-dihydro-5,8-dimethoxy-9,10-dioxo-anthracen-2-yl)tetrazole
  参考文献：
  名称：

  Anthraquinones related to rhein inhibit glucose uptake into chondrocytes. A mechanism for anti-osteoarthritis drugs?

  摘要：

  Rhein has been shown to inhibit the uptake of glucose into Ehrlich Ascites tumor cells. In this paper we show that a wide range of anthraquinones related to rhein can also inhibit glucose uptake into chondrocytes, many significantly more than the parent molecule. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00102-9

文献信息

• Pharmaceutical compounds
  申请人：Lilly Industries Limited

  公开号：US05484935A1

  公开（公告）日：1996-01-16

  Pharmaceutical compounds of the formula ##STR1## in which R.sup.1 and R.sup.3 are each C.sub.1-4 alkyl or C.sub.1-4 alkyl-carbonyl, and R.sup.2 is carboxy, tetrazolyl, C.sub.1-4 alkyl-sulphonamido or --CR.sup.4 R.sup.5 CO.sub.2 H where R.sup.4 and R.sup.5 are each hydrogen or C.sub.1-4 alkyl; provided that when R.sup.1 and R.sup.3 are both methyl and when R.sup.1 and R.sup.3 are both methylcarbonyl, R.sup.2 is not carboxy; and salts and esters thereof.

  化学物质的化学式为##STR1##其中R.sup.1和R.sup.3分别为C.sub.1-4烷基或C.sub.1-4烷基-羰基，R.sup.2为羧基、四唑基、C.sub.1-4烷基-磺酰胺基或--CR.sup.4R.sup.5CO.sub.2H，其中R.sup.4和R.sup.5分别为氢或C.sub.1-4烷基；但当R.sup.1和R.sup.3均为甲基且R.sup.1和R.sup.3均为甲基羰基时，R.sup.2不是羧基；以及其盐和酯。
• Anthraquinone derivatives useful in the treatment of cancer and osteoartritis
  申请人：LILLY INDUSTRIES LIMITED

  公开号：EP0638562A1

  公开（公告）日：1995-02-15

  Pharmaceutical compounds of the formula in which R¹ and R³ are each C₁₋₄ alkyl or C₁₋₄ alkyl-carbonyl, and R² is carboxy, tetrazolyl, C₁₋₄ alkyl-sulphonamido or -CR⁴R⁵CO₂H where R⁴ and R⁵ are each hydrogen or C₁₋₄ alkyl; provided that when R¹ and R³ are both methyl and when R¹ and R³ are both methylcarbonyl, R² is not carboxy; and salts and esters thereof.

  式中的药物化合物 其中 R¹ 和 R³ 各为 C₁₋₄ 烷基或 C₁₋₄ 烷基-羰基，R² 为羧基、四唑基、C₁₋₄ 烷基-磺酰胺基或-CR⁴R⁵CO₂H，其中 R⁴ 和 R⁵ 各为氢或 C₁₋₄ 烷基；但当 R¹ 和 R³ 都是甲基和当 R¹ 和 R³ 都是甲基羰基时，R² 不是羧基；以及它们的盐和酯。
• JPH07101944A
  申请人：——

  公开号：JPH07101944A

  公开（公告）日：1995-04-18
• US5484935A
  申请人：——

  公开号：US5484935A

  公开（公告）日：1996-01-16
• Anthraquinones related to rhein inhibit glucose uptake into chondrocytes. A mechanism for anti-osteoarthritis drugs?
  作者：Stephen L. Carney、Richard J. Broadmore、Rosemarie Tomlinson、Ann Kingston、Peter T. Gallagher、W.Martin Owton、Martin V. Miles、Michael Brunavs、Colin W. Smith、Terry A. Hicks、David R. Dobson、David J. Steggles、Samantha J. Ambler、Kelly A. Halliday

  DOI：10.1016/s0960-894x(97)00102-9

  日期：1997.1

  Rhein has been shown to inhibit the uptake of glucose into Ehrlich Ascites tumor cells. In this paper we show that a wide range of anthraquinones related to rhein can also inhibit glucose uptake into chondrocytes, many significantly more than the parent molecule. (C) 1997 Elsevier Science Ltd.